Icosavax is a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases. Icosavaxâ??s VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens, which it believes will induce broad, robust, and durable protection against the specific viruses targeted. Icosavaxâ??s pipeline includes vaccine candidates targeting respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Icosavax was formed in 2017 to advance the breakthrough VLP technology from the Institute for Protein Design at the University of Washington with the goal to discover, develop, and commercialize vaccines against infectious diseases.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Icosavax Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Icosavax Inc market cap is $766.86M.
What is the 52-week high for Icosavax Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Icosavax Inc 52 week high is $16.11 as of September 28, 2025.
What is the 52-week low for Icosavax Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Icosavax Inc 52 week low is $4.75 as of September 28, 2025.
What is Icosavax Inc stock price today?
Icosavax Inc stock price today is $15.31.
What was Icosavax Inc stock price yesterday?
Icosavax Inc stock price yesterday was $15.45.
What is the PE ratio of Icosavax Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Icosavax Inc’s P/E ratio is -6.89.
What is the Price-to-Book ratio of Icosavax Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Icosavax Inc P/B ratio is 3.3000.
What is Icosavax Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Icosavax Inc's EBITDA is -1.63.
What is the 50-day moving average of Icosavax Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Icosavax Inc 50-day moving average is $15.45.
